{"id":19629,"date":"2022-03-28T08:35:37","date_gmt":"2022-03-28T12:35:37","guid":{"rendered":"https:\/\/medicarereport.org\/?p=19629"},"modified":"2022-03-28T08:35:38","modified_gmt":"2022-03-28T12:35:38","slug":"the-fda-is-expected-to-authorize-2nd-boosters-for-people-50-and-up","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=19629","title":{"rendered":"The FDA is expected to authorize 2nd boosters for people 50 and up"},"content":{"rendered":"\n<p>(By Rob Stein and Jane Greenhalgh for NPR)<\/p>\n\n\n\n<p>Anyone 50 years and older could soon be eligible for a second booster dose of the Moderna or Pfizer-BioNtech COVID-19 vaccine. The Food and Drug Administration is expected to authorize the additional booster shots without holding a meeting of its independent vaccine advisors.  Continue reading <a href=\"https:\/\/www.npr.org\/sections\/health-shots\/2022\/03\/27\/1089072803\/the-fda-is-expected-to-authorize-2nd-boosters-for-people-50-and-up\" data-type=\"URL\" data-id=\"https:\/\/www.npr.org\/sections\/health-shots\/2022\/03\/27\/1089072803\/the-fda-is-expected-to-authorize-2nd-boosters-for-people-50-and-up\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"200\" height=\"72\" class=\"wp-image-3902\" style=\"width: 200px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png 152w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo-150x55.png 150w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:&nbsp;<\/strong>The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Rob Stein and Jane Greenhalgh for NPR) Anyone 50 years and older could soon be eligible for a second<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,52,15],"tags":[],"class_list":["post-19629","post","type-post","status-publish","format-standard","hentry","category-fda","category-pandemic","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19629"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19629\/revisions"}],"predecessor-version":[{"id":19630,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19629\/revisions\/19630"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}